Skip to main navigation Skip to search Skip to main content

Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis

Torkell Juulsgaad Ellingsen, I Hansen, J Thorsen, B Kuno Møller, Ulrik Tarp, S Jacobsen, Merete Lund Hetland, A Vestergaard, Kim Hørslev-Petersen, Kristian Stengaard-Pedersen

6 Citations (Scopus)

Abstract

To study the CD26 density on monocytes and CD4+ T-lymphocytes in steroid and DMARD-naïve, early rheumatoid arthritis (RA) patients and to analyse for correlations with disease activity, including long-term radiographic progression.
Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume30
Issue number1
Pages (from-to)58-63
Number of pages6
ISSN0392-856X
Publication statusPublished - 2012

Keywords

  • Adult
  • Aged
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • CD4-Positive T-Lymphocytes
  • Cyclosporine
  • Dipeptidyl Peptidase 4
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Methotrexate
  • Middle Aged
  • Monocytes
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this